I am a
Home I AM A Search Login

Papers of the Week

Papers: 2 Mar 2019 - 8 Mar 2019

Pharmacology/Drug Development

2019 Apr

CNS Drugs



Expanding Role of NMDA Receptor Antagonists in the Management of Pain.


Kreutzwiser D, Tawfic QA
CNS Drugs. 2019 Apr; 33(4):347-374.
PMID: 30826987.


Pain management is complex regardless of whether the pain is acute or chronic in nature or non-cancer or cancer related. In addition, relatively few pain pharmacotherapy options with adequate efficacy and safety data currently exist. Consequently, interest in the role of NMDA receptor antagonists as a pharmacological pain management strategy has surfaced. This narrative review provides an overview of the NMDA receptor and elaborates on the pharmacotherapeutic profile and pain management literature findings for the following NMDA receptor antagonists: ketamine, memantine, dextromethorphan, and magnesium. The literature on this topic is characterized by small studies, many of which exhibit methodological flaws. To date, ketamine is the most studied NMDA receptor antagonist for both acute and chronic pain management. Although further research about NMDA receptor antagonists for analgesia is needed and the optimal dosage/administration regimens for these drugs have yet to be determined, ketamine appears to hold the most promise and may be of particular value in the perioperative pain management realm.